University of Zurich clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 1 with a minor change only.

1. Notable

   DeEscO · Personalized Volume-deescalated Elective Nodal…DeEscO · Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma

   Primary completion pushed from Feb 28, 2029 to Sep 30, 2029

   Also in this update: Completion pushed from Feb 28, 2030 to Sep 30, 2030

   University of Zurich·Phase 2· NCT06563362· Registry history of NCT06563362 on ClinicalTrials.gov (opens the registry)

   Updated Oct 8, 2026

2. Notable

   EViDENCE-BT · Pharmacoscopy · Refractory Primary Brain Tumors

   Recruitment opened

   University of Zurich·Phase 2· NCT06804655· Registry history of NCT06804655 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

3. Notable

   BIOCARDIUM-HF · Molecular Underpinnings of Heart Failure…BIOCARDIUM-HF · Molecular Underpinnings of Heart Failure, Integrative Multi-Omics, and Non-Coding RNA Profiling

   Recruitment opened

   University of Zurich·Not specified· NCT07158086· Registry history of NCT07158086 on ClinicalTrials.gov (opens the registry)

   Updated Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.